INCR News and Press, Intercure Ltd.

NEW YORK and HERZLIYA, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company”) announced today that it received written confirmation from the Listing Qualifications Department of The Nasdaq Stock Market LLC (...

  Company intends to accelerate the rehabilitation of Canndoc’s flagship Nir Oz facility, supporting a return to full production and the Company’s expansion in the growing German medical cannabis market NEW YORK and HERZLIYA, Israel, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Int...

2026-06-22 09:03:23 ET More on InterCure Financial information for InterCure Read the full article on Seeking Alpha For further details see: InterCure secures up to NIS 54M financing

NEW YORK & HERZLIYA, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (dba Canndoc) (“ InterCure ” or the “ Company ”), today announced that, further to the Company’s prior reports regarding growing demand in Germany and ...

First Tranche Closing (50%) of Botanico Transaction Expands International Platform with Exclusive Access to U.S. Genetics, Premium Brands and Advanced AI-Driven Technologies; Company Reports Growing Demand in Germany and Evaluates Opportunities in Regulated U.S. Medical Cannabis Markets. NEW ...

2026-05-01 11:26:45 ET More on InterCure InterCure receives Nasdaq notification regarding minimum bid requirement Financial information for InterCure Read the full article on Seeking Alpha For further details see: InterCure reports FY results

The Company reported over NIS 270 million in revenue, NIS 37 million in Net loss, NIS 47 million in Adjusted EBITDA and NIS 17 million in positive operating cash flow, reflecting strong resilience and consistent profitability, with a twelfth consecutive half-year of positive Adjusted EBITDA, as t...

2026-03-03 16:50:56 ET More on InterCure Seeking Alpha’s Quant Rating on InterCure Financial information for InterCure Read the full article on Seeking Alpha For further details see: InterCure receives Nasdaq notification regarding minimum bid requ...

NEW YORK and HERZLIYA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“ InterCure ” or the “ Company ”) today announced that on February 25, 2026 the Company received a written notice (the “Notice”) from the Nasdaq...

InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA, marking its twelfth consecutive half-year of positive Adjusted EBITDA. Revenue for 2025 represents an increase of approximately 11% compared to 2024, while revenue for the second half of ...